BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38596321)

  • 1. Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country.
    Ho E; Vanderlinden A; Govaerts L; De Fooz B; Van Damme P; Michielsen P; Vanwolleghem T
    J Virus Erad; 2024 Mar; 10(1):100369. PubMed ID: 38596321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-Care Tests for Hepatitis B Are Associated with A Higher Linkage to Care and Lower Cost Compared to Venepuncture Sampling During Outreach Screenings in an Asian Migrant Population.
    Ho E; Michielsen P; Van Damme P; Ieven M; Veldhuijzen I; Vanwolleghem T
    Ann Glob Health; 2020 Jul; 86(1):81. PubMed ID: 32742939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals.
    Hyun CS; Ko O; Lee S; McMenamin J
    BMC Infect Dis; 2019 Jul; 19(1):638. PubMed ID: 31319805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.
    Koc ÖM; Kremer C; Hens N; Bielen R; Busschots D; Van Damme P; Robaeys G
    PLoS One; 2020; 15(7):e0234740. PubMed ID: 32716949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy.
    El-Hamad I; Pezzoli MC; Chiari E; Scarcella C; Vassallo F; Puoti M; Ciccaglione A; Ciccozzi M; Scalzini A; Castelli F;
    J Travel Med; 2015; 22(2):78-86. PubMed ID: 25424439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain.
    Picchio CA; Nomah DK; Rando-Segura A; Buti M; Lens S; Forns X; Tajes SR; Fernández E; Pamplona Portero J; Nuñez CL; van Selm L; MacKinnon M; Araujo SG; Martró E; Rodríguez-Frías F; Lazarus JV
    Commun Med (Lond); 2023 Dec; 3(1):182. PubMed ID: 38097770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus (HBV) screening, linkage and retention-in-care in inclusion health populations: Evaluation of an outreach screening programme in London.
    Martyn E; O'Regan S; Harris P; Leonard M; Veitch M; Sultan B; Matthews PC; Ghosh I; Story A; Surey J
    J Infect; 2024 Feb; 88(2):167-172. PubMed ID: 38159579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    Evans H; Balasegaram S; Douthwaite S; Hunter L; Kulasegaram R; Wong T; Querol-Rubiera A; Nebbia G
    PLoS One; 2018; 13(7):e0198520. PubMed ID: 30044779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B screening in an argentine ED: Increasing vaccination in a resource-limited setting.
    Ford JS; Marianelli LG; Frassone N; Debes JD
    Am J Emerg Med; 2020 Feb; 38(2):296-299. PubMed ID: 31353159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C.
    Radzi Ah M; S Tan S; Mohamed R; Jaya F; K S; C Aun A; A Kutty G; S Wong H; Abdullah R; R Seman M; Al Mahtab M; Morad Z; Lim TO
    Euroasian J Hepatogastroenterol; 2018; 8(2):101-107. PubMed ID: 30828549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021.
    Nartey YA; Okine R; Seake-Kwawu A; Ghartey G; Asamoah YK; Senya K; Duah A; Owusu-Ofori A; Amugsi J; Suglo D; Bampoh SA; Hiebert L; Njuguna H; Ward JW; Plymoth A; Roberts LR; Bockarie AS; Awuku YA; Obiri-Yeboah D
    BMC Public Health; 2022 Nov; 22(1):2149. PubMed ID: 36419017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study.
    Demirturk N; Demirdal T
    Clin Mol Hepatol; 2014 Mar; 20(1):56-60. PubMed ID: 24757659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study.
    Karatapanis S; Skorda L; Marinopoulos S; Papastergiou V; Drogosi M; Lisgos P; Antsaklis A
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):878-83. PubMed ID: 22588307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.
    Chisenga CC; Musukuma K; Chilengi R; Zürcher S; Munamunungu V; Siyunda A; Ojok D; Bauer S; Wandeler G; Vinikoor M;
    J Clin Virol; 2018 Jan; 98():5-7. PubMed ID: 29175231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda.
    Makuza JD; Rwema JOT; Ntihabose CK; Dushimiyimana D; Umutesi J; Nisingizwe MP; Serumondo J; Semakula M; Riedel DJ; Nsanzimana S
    BMC Infect Dis; 2019 May; 19(1):381. PubMed ID: 31053097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
    Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic Disparities in Hepatitis B Virus Infection Among 1 Million Reproductive-Age Couples Preparing for Pregnancy in the Rural Yunnan, China: A Population-Based Cross-Sectional Study.
    Jing W; Yuan Y; Liu M; Ye H; Kong C; Liu J; Wu Y
    Front Med (Lausanne); 2021; 8():799873. PubMed ID: 35155476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.